Statistical Analysis of Clinical COVID-19 Data: A Concise Overview of Lessons Learned, Common Errors and How to Avoid Them

被引：38

作者：

Wolkewitz, Martin ^{[1
]}

Lambert, Jerome ^{[1
]}

von Cube, Maja ^{[1
]}

Bugiera, Lars ^{[1
]}

Grodd, Marlon ^{[1
]}

Hazard, Derek ^{[1
]}

White, Nicole ^{[2
]}

Barnett, Adrian ^{[2
]}

Kaier, Klaus ^{[1
]}

机构：

[1] Univ Freiburg, Med Ctr, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany

[2] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia

来源：

CLINICAL EPIDEMIOLOGY | 2020年 / 12卷

关键词：

competing risk bias; immortal-time bias; competing events; time-dependent bias; time-varying exposure; time-to-event analysis; COMPETING RISKS; TIME; INFECTIONS; HAZARDS;

D O I：

10.2147/CLEP.S256735

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

By definition, in-hospital patient data are restricted to the time between hospital admission and discharge (alive or dead). For hospitalised cases of COVID-19, a number of events during hospitalization are of interest regarding the influence of risk factors on the likelihood of experiencing these events. The same is true for predicting times from hospital admission of COVID-19 patients to intensive care or from start of ventilation (invasive or non-invasive) to extubation. This logical restriction of the data to the period of hospitalisation is associated with a substantial risk that inappropriate methods are used for analysis. Here, we briefly discuss the most common types of bias which can occur when analysing inhospital COVID-19 data.

引用

页码：925 / 928

页数：4

共 50 条

[31] Role of the Clinical Data Managers During the COVID-19 Pandemic: An Overview
Sajja, Rishitha
REVIEWS ON RECENT CLINICAL TRIALS, 2023, 18 (01) : 41 - 45
[32] Medicine Allotment for COVID-19 Patients by Statistical Data Analysis
Vardhini, P. A. Harsha
Prasad, S. Shiva
Korra, Seena Naik
2021 INTERNATIONAL CONFERENCE ON EMERGING SMART COMPUTING AND INFORMATICS (ESCI), 2021, : 665 - 669
[33] Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19
Ackroyd, Sarah A.
Walls, Melinique
Kim, Josephine S.
Lee, Nita K.
GYNECOLOGIC ONCOLOGY REPORTS, 2022, 41
[34] Lessons learned: Development of COVID-19 clinical staging models at a large urban research institution
Huang, Sean S.
Chaisson, Lelia H.
Galanter, William
Jalali, Arash
Menchaca, Martha
Parde, Natalie
Rodriguez-Fernandez, Jorge M.
Trotter, Andrew
Kochendorfer, Karl M.
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
[35] The World of Clinical Trial Development Post COVID-19: Lessons Learned from a Global Pandemic
Karzai, Fatima
Madan, Ravi A.
Dahut, William L.
CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4198 - 4200
[36] A Statistical Non-Parametric data analysis for COVID-19 incidence data
Minu, R.I.
Nagarajan, G.
ISA Transactions, 2022, 130 : 675 - 683
[37] A Statistical Non-Parametric data analysis for COVID-19 incidence data
Minu, R. I.
Nagarajan, G.
ISA TRANSACTIONS, 2022, 130 : 675 - 683
[38] Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic
Drews, Steven J.
O'Brien, Sheila F.
VIRUSES-BASEL, 2022, 14 (10):
[39] Potential sources of bias in the analysis of COVID-19 vaccine safety during pregnancy: How the embryotox study plans to avoid them by design and analysis methods
Stegherr, Regina
Kayser, Angela
Padberg, Stephanie
Dathe, Katarina
NEUROTOXICOLOGY AND TERATOLOGY, 2022, 92
[40] Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia
Sinuraya, Rano K.
Nuwarda, Rina F.
Postma, Maarten J.
Suwantika, Auliya A.
GLOBALIZATION AND HEALTH, 2024, 20 (01)

← 1 2 3 4 5 →